Andrew M Tershakovec

Andrew M Tershakovec

UNVERIFIED PROFILE

Are you Andrew M Tershakovec?   Register this Author

Register author
Andrew M Tershakovec

Andrew M Tershakovec

Publications by authors named "Andrew M Tershakovec"

Are you Andrew M Tershakovec?   Register this Author

94Publications

1674Reads

20Profile Views

Medication Discontinuation in the IMPROVE-IT Trial.

Circ Cardiovasc Qual Outcomes 2019 Jan;12(1):e005041

Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., M.T.R., J.A.W., Y.L., L.K.N., M.A.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.118.005041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541480PMC
January 2019

Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status.

Am J Cardiol 2018 11 4;122(9):1451-1458. Epub 2018 Aug 4.

Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.07.034DOI Listing
November 2018

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

Circulation 2017 Dec 30;136(25):2440-2450. Epub 2017 Sep 30.

TIMI Study Group, Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.A.B., S.D.W., R.P.G., J.-G.P., S.A.M., C.P.C., E.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.029095DOI Listing
December 2017

Statin combination therapy and cardiovascular risk reduction.

Future Cardiol 2016 05 15;12(3):289-315. Epub 2016 Apr 15.

Merck & Co., Inc., Kenilworth, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fca-2015-0011DOI Listing
May 2016

Changing characteristics of statin-related cIMT trials from 1988 to 2006.

Atherosclerosis 2016 Mar 25;246:121-9. Epub 2015 Nov 25.

Global Clinical Development, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2015.11.023DOI Listing
March 2016

Time-related trends in variability of cIMT changes in statin trials.

Data Brief 2016 Mar 30;6:530-41. Epub 2015 Dec 30.

Global Clinical Development, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dib.2015.12.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724693PMC
March 2016

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.

J Am Coll Cardiol 2016 Feb;67(4):353-361

TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2015.10.077DOI Listing
February 2016

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.

Circulation 2015 Sep 1;132(13):1224-33. Epub 2015 Sep 1.

From TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.A.B., R.P.G., C.P.C., J.Z., S.A.M., E.B.); Duke Clinical Research Institute, Durham, NC (J.W., M.A.B.); and Merck, Kenilworth, NJ (A.M.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.018381DOI Listing
September 2015

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

N Engl J Med 2015 Jun 3;372(25):2387-97. Epub 2015 Jun 3.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital, and Harvard Medical School, Boston (C.P.C., R.P.G., A.M., K.I., E.A.B., S.D.W., E.B.); Duke Clinical Research Institute (DCRI), Durham, NC (M.A.B., J.A.W., C.R., R.M.C.); Montreal Heart Institute, Montreal (P.T.); Vivantes Neukölln Medical Center, Berlin (H.D.); Lady Davis Carmel Medical Center, Haifa, Israel (B.S.L.); Canisius-Wilhelmina Ziekenhuis, Nijmegen (T.O.O.), and the Netherlands Leiden University Medical Center, Leiden (J.W.J.) - both in the Netherlands; Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy (G.M.D.F.); National Institute of Cardiology, Warsaw, Poland (W.R.); and Merck, Kenilworth, NJ (P.D.L., A.M.T., T.A.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1410489DOI Listing
June 2015

Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.

Atherosclerosis 2014 Dec 4;237(2):829-37. Epub 2014 Nov 4.

Merck & Co., Inc., One Merck Drive, Whitehouse Station, NJ 07090, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2014.10.105DOI Listing
December 2014

Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.

J Clin Lipidol 2013 Jul-Aug;7(4):292-303. Epub 2013 Apr 3.

Department of Epidemiology & Medicine,Prevention Intervention Center, College of Public Health, University of Iowa College of Public Health, 105 River Street, S455 CPBH, Iowa City, IA 52242, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2013.03.007DOI Listing
October 2013

Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patients.

Atherosclerosis 2012 Dec 13;225(2):388-96. Epub 2012 Sep 13.

Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2012.09.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749834PMC
December 2012

Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.

Metab Syndr Relat Disord 2012 Aug 8;10(4):260-6. Epub 2012 Mar 8.

L-Marc, Louisville, Kentucky, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/met.2012.0005DOI Listing
August 2012

Intestinal sterol transporters and cholesterol absorption inhibition.

Curr Opin Lipidol 2011 Dec;22(6):467-78

Merck Research Laboratories, Merck Sharp & Dohme Corp./Merck & Co., Inc., Whitehouse Station, New Jersey, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-lipidology/2011/12000/Intest
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MOL.0b013e32834c7c28DOI Listing
December 2011

Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial).

Am J Cardiol 2011 Jul 10;108(1):40-6. Epub 2011 May 10.

Center for Human Nutrition, Departments of Internal Medicine and Clinical Nutrition, University of Texas Southwestern Medical Center, and Metabolic Unit, Veterans Affairs Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2011.03.003DOI Listing
July 2011

Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis.

Curr Med Res Opin 2011 Jun 7;27(6):1191-210. Epub 2011 Apr 7.

Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), University College London (UCL) Medical School, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2011.571239DOI Listing
June 2011

Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients.

J Clin Lipidol 2010 Mar-Apr;4(2):126-32. Epub 2010 Feb 6.

Division of Cardiovascular Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2010.01.007DOI Listing
May 2011

Lipid lowering for secondary prevention of cardiovascular disease in older adults.

Drugs Aging 2010 Dec;27(12):959-72

Division of Cardiology, University of Kentucky, Lexington, Kentucky, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11539550-000000000-00000DOI Listing
December 2010

Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?

Lipids Health Dis 2010 Nov 30;9:136. Epub 2010 Nov 30.

Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-511X-9-136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012666PMC
November 2010

Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo.

Rheumatology (Oxford) 2009 Sep 9;48(9):1122-7. Epub 2009 Jul 9.

Division of Rheumatology, Johns Hopkins University, Baltimore, MD 21224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kep184DOI Listing
September 2009

Progress and controversies: treating obesity and insulin resistance in the context of hypertension.

J Clin Hypertens (Greenwich) 2009 Jan;11(1):36-41

Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7176.2008.00065.xDOI Listing
January 2009

Ezetimibe: cholesterol lowering and beyond.

Expert Rev Cardiovasc Ther 2008 Apr;6(4):447-70

Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Avenue, Louisville, KY 40213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14779072.6.4.447DOI Listing
April 2008

Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.

J Am Coll Cardiol 2008 Apr;51(16):1564-72

Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2008.03.003DOI Listing
April 2008

Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study.

Diabetes Care 2008 Mar 10;31(3):445-7. Epub 2007 Dec 10.

Merck Research Laboratories, Merck & Co., Inc., Upper Gwynedd, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc07-0196DOI Listing
March 2008

Efficacy of simvastatin therapy in attainment of LDL-C and TG goal levels in patients with type 2 diabetic dyslipidemia.

J Clin Lipidol 2008 Feb 30;2(1):12-8. Epub 2008 Jan 30.

Johns Hopkins University School of Medicine, 1830 E Monument Street, Suite 328, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2007.12.001DOI Listing
February 2008

Lipoprotein and apolipoprotein ratios in the VYTAL trial of ezetimibe/simvastatin compared with atorvastatin in type 2 diabetes.

J Clin Lipidol 2008 Feb 6;2(1):19-24. Epub 2008 Jan 6.

Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, Box 3510, Duke University, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S193328740800002
Publisher Site
http://dx.doi.org/10.1016/j.jacl.2007.12.004DOI Listing
February 2008

Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes.

J Clin Lipidol 2008 Feb 11;2(1):25-35. Epub 2008 Jan 11.

Division of Endocrinology, Diabetes and Metabolism, SUNY Upstate Medical University and VA Medical Center, 750 E. Adams Street, CWB 353, Syracuse, NY 13210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2008.01.001DOI Listing
February 2008

The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain.

Curr Med Res Opin 2007 Jan;23(1):195-206

University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/030079907X162647DOI Listing
January 2007

Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.

Mayo Clin Proc 2006 Dec;81(12):1579-88

Diabetes Research Institute, Miller School of Medicine, University of Miami, 1450 NW 10th Ave, Miami, FL 33136, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4065/81.12.1579DOI Listing
December 2006

Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome.

Diab Vasc Dis Res 2006 Sep;3(2):93-102

University of Texas Health Science Center in San Antonio, Kerrville, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3132/dvdr.2006.020DOI Listing
September 2006

Calcium and dairy intake and measures of obesity in hyper- and normocholesterolemic children.

Obes Res 2005 Oct;13(10):1727-38

Department of Nutrition, Food Studies, and Public Health, New York University, New York, NY 10012, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/oby.2005.211DOI Listing
October 2005

Psychological considerations in pediatric weight management.

Obes Res 2004 Oct;12(10):1537-8

Clinical Development, U.S. Human Health, Merck and Co., Inc., P.O. Box 4, BLA 20, Sumneytown Pike, West Point, PA 19486, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/oby.2004.192DOI Listing
October 2004

Prediction equations for resting energy expenditure in overweight and normal-weight black and white children.

Am J Clin Nutr 2004 Aug;80(2):365-73

Unit on Growth and Obesity, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267722PMC
http://dx.doi.org/10.1093/ajcn/80.2.365DOI Listing
August 2004

Obesity during childhood and adolescence augments bone mass and bone dimensions.

Am J Clin Nutr 2004 Aug;80(2):514-23

Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, 34th Street and Civic Center Boulevard, Philadelphia. PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcn/80.2.514DOI Listing
August 2004

HIV-related lipodystrophy and related factors.

Atherosclerosis 2004 May;174(1):1-10

Division of Gastroenterology and Nutrition, Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0021-9150(03)00246-6DOI Listing
May 2004

Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial.

JAMA 2003 Apr;289(14):1805-12

Department of Psychiatry, Weight and Eating Disorders Program, University of Pennsylvania School of Medicine, Philadelphia 19104-3309, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.289.14.1805DOI Listing
April 2003

Ethnicity, insurance type, and follow-up in a pediatric weight management program.

Obes Res 2003 Jan;11(1):17-20

The Children's Hospital of Philadelphia, Division of Gastroenterology and Nutrition Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/oby.2003.4DOI Listing
January 2003

Persistent hypercholesterolemia is associated with the development of obesity among girls: the Bogalusa Heart Study.

Am J Clin Nutr 2002 Oct;76(4):730-5

Division of Gastroenterology and Nutrition, The Children's Hospital of Philadelphia, PA 19104-4399, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/ajcn/article/76/4/730/4677436
Publisher Site
http://dx.doi.org/10.1093/ajcn/76.4.730DOI Listing
October 2002

Age, sex, ethnicity, body composition, and resting energy expenditure of obese African American and white children and adolescents.

Am J Clin Nutr 2002 May;75(5):867-71

Division of Gastroenterology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcn/75.5.867DOI Listing
May 2002